|
TBCE expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.85499999991879E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.91740000000352E-05 |
| Normal-vs-Stage2 |
1.216250E-02 |
| Normal-vs-Stage3 |
1.455030E-03 |
| Normal-vs-Stage4 |
8.700000E-03 |
| Stage1-vs-Stage2 |
6.517200E-01 |
| Stage1-vs-Stage3 |
8.324400E-01 |
| Stage1-vs-Stage4 |
5.146000E-01 |
| Stage2-vs-Stage3 |
7.871400E-01 |
| Stage2-vs-Stage4 |
4.029200E-01 |
| Stage3-vs-Stage4 |
4.594600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.12039999999869E-06 |
| Normal-vs-AfricanAmerican |
8.837600E-02 |
| Normal-vs-Asian |
3.932400E-01 |
| Caucasian-vs-AfricanAmerican |
9.191200E-01 |
| Caucasian-vs-Asian |
9.623200E-01 |
| AfricanAmerican-vs-Asian |
9.446000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.681000E-03 |
| Normal-vs-Female |
8.80110000434087E-08 |
| Male-vs-Female |
1.444100E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.219200E-01 |
| Normal-vs-Age(41-60Yrs) |
7.812600E-04 |
| Normal-vs-Age(61-80Yrs) |
1.78524999999707E-05 |
| Normal-vs-Age(81-100Yrs) |
9.225000E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.302000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.426250E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.112140E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.297400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.311600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.530200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
6.594100E-02 |
| Normal-vs-Grade 2 |
8.49560000000249E-05 |
| Normal-vs-Grade 3 |
4.172100E-04 |
| Normal-vs-Grade 4 |
1.574260E-02 |
| Grade 1-vs-Grade 2 |
2.031400E-01 |
| Grade 1-vs-Grade 3 |
2.211600E-01 |
| Grade 1-vs-Grade 4 |
1.929210E-01 |
| Grade 2-vs-Grade 3 |
8.220800E-01 |
| Grade 2-vs-Grade 4 |
8.433600E-01 |
| Grade 3-vs-Grade 4 |
7.265200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.81517081552374E-13 |
| Normal-vs-ccB subtype |
3.421200E-01 |
| ccA subtype-vs-ccB subtype |
1.53063999999148E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.5265000000011E-05 |
| Normal-vs-N1 |
4.569000E-01 |
| N0-vs-N1 |
9.806800E-01 |
|
|
